IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 109 filers reported holding IGM BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55 | -8.3% | 6,527 | +0.8% | 0.00% | – |
| Q2 2023 | $60 | -32.6% | 6,473 | -0.3% | 0.00% | – |
| Q1 2023 | $89 | -19.1% | 6,495 | 0.0% | 0.00% | – |
| Q4 2022 | $110 | -99.9% | 6,495 | +0.1% | 0.00% | – |
| Q3 2022 | $148,000 | +27.6% | 6,489 | +0.6% | 0.00% | – |
| Q2 2022 | $116,000 | -32.9% | 6,452 | -0.3% | 0.00% | – |
| Q1 2022 | $173,000 | -8.9% | 6,470 | +0.0% | 0.00% | – |
| Q4 2021 | $190,000 | -55.4% | 6,467 | -0.2% | 0.00% | – |
| Q3 2021 | $426,000 | -34.9% | 6,481 | -17.5% | 0.00% | -100.0% |
| Q2 2021 | $654,000 | +31.3% | 7,859 | +20.9% | 0.00% | 0.0% |
| Q1 2021 | $498,000 | -13.2% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $574,000 | +19.6% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $480,000 | +1.1% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $475,000 | +87.7% | 6,500 | +44.4% | 0.00% | – |
| Q1 2020 | $253,000 | +47.1% | 4,500 | 0.0% | 0.00% | – |
| Q4 2019 | $172,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |